CHPI Advisory Board

Mary G Griffith (J.D., M.B.A., B.A.)

Mary Griffith is a member of both the New York and Ontario Bars. Her practice focuses on business law matters, particularly regulatory, advertising and marketing issues, and on developing preventive and practical approaches to business situations. She is a consultant to Advertising Standards Canada and has spoken at many conferences on a variety of legal issues. Prior to obtaining her law degree, Ms. Griffith had an extensive business career, holding a number of senior marketing executive positions with major multi-national corporations. She has also provided strategic business counsel to a team of legal and commercial consultants in the assessment and creation of joint ventures and investments both domestically and internationally. She holds a B.A. from Queen's University, an M.B.A. from the University of Toronto, and received her law degree from Osgood Hall Law School. 

Mark Mullins (Ph.D., M.A., B.A.)

Dr. Mark Mullins has a B.A. from the University of Saskatchewan, an M.A. from the University of Western Ontario and a Ph.D. from the London School of Economics. He also studied for a year in Taiwan and at the University of Hong Kong. From 1990 to 1998, Dr. Mullins was Chief Economist and Head of Fixed Income Research at Midland Walwyn Capital. He then served as President of MSG Hedge Corporation. In 2003, Dr. Mullins joined the Fraser Institute as its Executive Director until 2009. He has most recently been CEO of Veras Inc., a consulting and advisory firm specializing in finance and economics, and a global macro portfolio manager. He has served as economic and fiscal policy advisor to a number of Canadian political parties at the provincial and federal level. He was a founding member of Ontario’s Task Force on Competitiveness, Productivity and Economic Progress and a former council member with NSERC, the Canadian federal government’s natural sciences and engineering research granting agency.

Brett J Skinner (Ph.D., M.A., B.A.), Founder & CEO

Brett J Skinner is the Founder and CEO of Canadian Health Policy Institute (CHPI) and the Editor of CHPI's online journal Canadian Health Policy. Dr. Skinner was previously Executive Director Health and Economic Policy at Innovative Medicines Canada (2013 to 2017); and he was also previously CEO (2010 to 2012) and Director of Health Policy Studies (2004 to 2012) at Fraser Institute. Dr. Skinner has a B.A. from the University of Windsor, an M.A. through joint studies between the University of Windsor and Wayne State University (Detroit), and a Ph.D. from Western University (aka University of Western Ontario, London), where he has lectured in both the Faculty of Health Sciences and the Department of Political Science. Dr. Skinner is the principal author or co-author of one book and over 60 major health policy research publications. His work has been published by think-tanks including Canadian Health Policy Institute (Toronto), Fraser Institute (Vancouver), Atlantic Institute for Market Studies (Halifax), Pacific Research Institute (San Francisco), Israel National Institute for Health Policy and Health Services Research (Tel Aviv), Galen Institute (Washington, D.C.), International Policy Network (London) and American Enterprise Institute (Washington, D.C.). His work has also been published in academic journals including Economic AffairsPharmacoeconomics,  and Alimentary Pharmacology & Therapeutics. In 2003 he was a co-author on a project that won the Atlas Economic Research Foundation’s Sir Antony Fisher Memorial Award for innovative projects in public policy. Dr. Skinner’s book, Canadian Health Policy Failures: What’s wrong? Who gets hurt? Why nothing changes, was a finalist for Atlas’ 2009 Fisher book prize. He has also authored hundreds of opinion-editorials published in National Post, Financial Post, Globe and Mail, Toronto Sun, Ottawa Citizen, La Presse, Montreal Gazette, Calgary Herald, Vancouver Sun, Chicago Sun Times, and other major daily newspapers. Dr. Skinner appears and is cited frequently as a health policy expert in the media. He has presented his research at conferences and events in Canada, the United States, Israel and South Africa. Dr. Skinner has provided expert testimony about his research in several Canadian legal cases, and he has testified on three occasions before the House of Commons Standing Committee on Health in Ottawa. He has also briefed bi-partisan Congressional policy staff at the U.S. Capitol in Washington, D.C.